Evidence map›Paper›PMID 30809524›Full record

ArticleFrontiers in medicine2019

Theo Crawford, Nicholas Fletcher, Margaret Veitch, Jazmina L Gonzalez Cruz, Nicola Pett, Ian Brereton, James W Wells, Mehdi Mobli, Yasvir Tesiram

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Theo CrawfordCentre for Advanced Imaging (CAI), The University of Queensland, Brisbane, QLD, Australia.
Nicholas FletcherCentre for Advanced Imaging (CAI), The University of Queensland, Brisbane, QLD, Australia.
Margaret VeitchFaculty of Medicine, Translational Research Institute, University of Queensland Diamantina Institute, Brisbane, QLD, Australia.
Jazmina L Gonzalez CruzFaculty of Medicine, Translational Research Institute, University of Queensland Diamantina Institute, Brisbane, QLD, Australia.
Nicola PettFaculty of Medicine, Translational Research Institute, University of Queensland Diamantina Institute, Brisbane, QLD, Australia.
Ian BreretonCentre for Advanced Imaging (CAI), The University of Queensland, Brisbane, QLD, Australia.
James W WellsFaculty of Medicine, Translational Research Institute, University of Queensland Diamantina Institute, Brisbane, QLD, Australia.
Mehdi MobliCentre for Advanced Imaging (CAI), The University of Queensland, Brisbane, QLD, Australia.
Yasvir TesiramCentre for Advanced Imaging (CAI), The University of Queensland, Brisbane, QLD, Australia.
University of Queensland · AUTranslational Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Squamous cell carcinoma (SCC) accounts for the majority of non-melanoma skin cancer related deaths, particularly in immunosuppressed persons. Identification of biomarkers that could be used to identify or treat SCC would be of significant benefit. The anthrax toxin receptors, Tumor Endothelial Marker 8 (TEM8) and Capillary Morphogenesis Gene 2 (CMG2), are endothelial receptors involved in extracellular matrix homeostasis and angiogenesis that are selectively upregulated on numerous tumors. One method of targeting these receptors is Protective Antigen (PA), a protein produced by

Indexed as

anthrax toxin receptorsCapillary Morphogenesis Gene 2cutaneous squamous cell carcinomaoptical imagingProtective Antigenskin cancerTumor Endothelial Marker 8

Identifiers

PMID30809524
PMCPMC6379334
OpenAlexW2914304623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.